321 related articles for article (PubMed ID: 15249612)
1. Onset and rate of striatal atrophy in preclinical Huntington disease.
Aylward EH; Sparks BF; Field KM; Yallapragada V; Shpritz BD; Rosenblatt A; Brandt J; Gourley LM; Liang K; Zhou H; Margolis RL; Ross CA
Neurology; 2004 Jul; 63(1):66-72. PubMed ID: 15249612
[TBL] [Abstract][Full Text] [Related]
2. Striatal volume contributes to the prediction of onset of Huntington disease in incident cases.
Aylward EH; Liu D; Nopoulos PC; Ross CA; Pierson RK; Mills JA; Long JD; Paulsen JS;
Biol Psychiatry; 2012 May; 71(9):822-8. PubMed ID: 21907324
[TBL] [Abstract][Full Text] [Related]
3. Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study.
Kipps CM; Duggins AJ; Mahant N; Gomes L; Ashburner J; McCusker EA
J Neurol Neurosurg Psychiatry; 2005 May; 76(5):650-5. PubMed ID: 15834021
[TBL] [Abstract][Full Text] [Related]
4. Genetic load determines atrophy in hand cortico-striatal pathways in presymptomatic Huntington's disease.
Hong Y; O'Donnell LJ; Savadjiev P; Zhang F; Wassermann D; Pasternak O; Johnson H; Paulsen J; Vonsattel JP; Makris N; Westin CF; Rathi Y
Hum Brain Mapp; 2018 Oct; 39(10):3871-3883. PubMed ID: 29797744
[TBL] [Abstract][Full Text] [Related]
5. Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's disease.
Harris GJ; Pearlson GD; Peyser CE; Aylward EH; Roberts J; Barta PE; Chase GA; Folstein SE
Ann Neurol; 1992 Jan; 31(1):69-75. PubMed ID: 1531910
[TBL] [Abstract][Full Text] [Related]
6. Onset and progression of pathologic atrophy in Huntington disease: a longitudinal MR imaging study.
Hobbs NZ; Barnes J; Frost C; Henley SM; Wild EJ; Macdonald K; Barker RA; Scahill RI; Fox NC; Tabrizi SJ
AJNR Am J Neuroradiol; 2010 Jun; 31(6):1036-41. PubMed ID: 20150305
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted versus volumetric imaging of the striatum in early symptomatic Huntington disease.
Vandenberghe W; Demaerel P; Dom R; Maes F
J Neurol; 2009 Jan; 256(1):109-14. PubMed ID: 19267169
[TBL] [Abstract][Full Text] [Related]
8. Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study.
Peinemann A; Schuller S; Pohl C; Jahn T; Weindl A; Kassubek J
J Neurol Sci; 2005 Dec; 239(1):11-9. PubMed ID: 16185716
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal change in basal ganglia volume in patients with Huntington's disease.
Aylward EH; Li Q; Stine OC; Ranen N; Sherr M; Barta PE; Bylsma FW; Pearlson GD; Ross CA
Neurology; 1997 Feb; 48(2):394-9. PubMed ID: 9040728
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat.
Ruocco HH; Bonilha L; Li LM; Lopes-Cendes I; Cendes F
J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):130-5. PubMed ID: 17615168
[TBL] [Abstract][Full Text] [Related]
11. Regional subcortical shape analysis in premanifest Huntington's disease.
Tang X; Ross CA; Johnson H; Paulsen JS; Younes L; Albin RL; Ratnanather JT; Miller MI
Hum Brain Mapp; 2019 Apr; 40(5):1419-1433. PubMed ID: 30376191
[TBL] [Abstract][Full Text] [Related]
12. Decreased diffusivity in the caudate nucleus of presymptomatic huntington disease gene carriers: which explanation?
Mandelli ML; Savoiardo M; Minati L; Mariotti C; Aquino D; Erbetta A; Genitrini S; Di Donato S; Bruzzone MG; Grisoli M
AJNR Am J Neuroradiol; 2010 Apr; 31(4):706-10. PubMed ID: 19942704
[TBL] [Abstract][Full Text] [Related]
13. Huntington's disease: the relationship between clinical signs, CAG repeats and the atrophy of the caudate nucleus in CT scans.
Roth J; Zidovská J; Růzicková S; Havrdová E; Preiss M; Uhrová T; Línek V; Doubek P; Volfová M; Jech R; Bauer J; Růzicka E
Sb Lek; 1999; 100(1):39-44. PubMed ID: 10860124
[TBL] [Abstract][Full Text] [Related]
14. Decreased striatal monoaminergic terminals in Huntington disease.
Bohnen NI; Koeppe RA; Meyer P; Ficaro E; Wernette K; Kilbourn MR; Kuhl DE; Frey KA; Albin RL
Neurology; 2000 May; 54(9):1753-9. PubMed ID: 10802780
[TBL] [Abstract][Full Text] [Related]
15. Basal ganglia volume and proximity to onset in presymptomatic Huntington disease.
Aylward EH; Codori AM; Barta PE; Pearlson GD; Harris GJ; Brandt J
Arch Neurol; 1996 Dec; 53(12):1293-6. PubMed ID: 8970459
[TBL] [Abstract][Full Text] [Related]
16. Striatal morphology correlates with frontostriatal electrophysiological motor processing in Huntington's disease: an IMAGE-HD study.
Turner LM; Jakabek D; Wilkes FA; Croft RJ; Churchyard A; Walterfang M; Velakoulis D; Looi JC; Georgiou-Karistianis N; Apthorp D
Brain Behav; 2016 Dec; 6(12):e00511. PubMed ID: 28031992
[TBL] [Abstract][Full Text] [Related]
17. Detection of Huntington's disease decades before diagnosis: the Predict-HD study.
Paulsen JS; Langbehn DR; Stout JC; Aylward E; Ross CA; Nance M; Guttman M; Johnson S; MacDonald M; Beglinger LJ; Duff K; Kayson E; Biglan K; Shoulson I; Oakes D; Hayden M;
J Neurol Neurosurg Psychiatry; 2008 Aug; 79(8):874-80. PubMed ID: 18096682
[TBL] [Abstract][Full Text] [Related]
18. Striatal and extrastriatal atrophy in Huntington's disease and its relationship with length of the CAG repeat.
Ruocco HH; Lopes-Cendes I; Li LM; Santos-Silva M; Cendes F
Braz J Med Biol Res; 2006 Aug; 39(8):1129-36. PubMed ID: 16906288
[TBL] [Abstract][Full Text] [Related]
19. Elevated brain iron is independent from atrophy in Huntington's Disease.
Dumas EM; Versluis MJ; van den Bogaard SJ; van Osch MJ; Hart EP; van Roon-Mom WM; van Buchem MA; Webb AG; van der Grond J; Roos RA;
Neuroimage; 2012 Jul; 61(3):558-64. PubMed ID: 22480728
[TBL] [Abstract][Full Text] [Related]
20. Freesurfer Software Update Significantly Impacts Striatal Volumes in the Huntington's Disease Young Adult Study and Will Influence HD-ISS Staging.
Knights H; Coleman A; Hobbs NZ; Tabrizi SJ; Scahill RI;
J Huntingtons Dis; 2024; 13(1):77-90. PubMed ID: 38489194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
